Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis

Bitop

Status: Completed

Conditions: Allergic Rhinitis

Treatments: Other: Medica device, drug-like

Study type: Observational

Funder types: Industry

Identifiers

NCT02131038

Rep-25

Details and patient eligibility

About

This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Cromoglycid acid containing nasal spray. The patient applies Ectoin Allergy Nasal Spray or Cromoglycid acid containing nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and by the patient in a dairy at defined time intervalls.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female or male individuals ≥ 18 years
• Patients with proven Allergic Rhinitis which are treated with Ectoin Nasal Spray or -Cromoglycic acid nasal Spray during the observational period

Exclusion criteria

• Contra indications according to the label

Trial design

50 participants in 2 patient groups

Ectoin group

Description:

Ectoin Allergy Nasal Spray

Treatment:

Other: Medica device, drug-like

Cromolyn group

Description:

Cromolyn sodium